Flecainide
فلکائینید
❤️ Cardiovascular SystemClass IC antiarrhythmic
Market / country: 🇺🇸 USA
Tambocor (US)
🧮 Dose calculator
Atrial fibrillation / anticoagulation · Regimen source: FDA Flecainide · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Pre-existing 2nd/3rd-degree AV block or bifascicular block without a pacemaker; cardiogenic shock; hypersensitivity. FDA Flecainide · Contraindications
Warnings
- • Boxed warning: excess mortality after MI (CAST); not recommended for chronic AF; proarrhythmic effects. FDA Flecainide · Warnings
Formulations
- 50 mg tablet — tablet 🇺🇸 USA FDA Flecainide · How Supplied
- 100 mg tablet (scored) — tablet 🇺🇸 USA FDA Flecainide · How Supplied
- 150 mg tablet (scored) — tablet 🇺🇸 USA FDA Flecainide · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Flecainide · Precautions/Warnings – Pregnancy
“Pregnancy Category C.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Flecainide · Precautions/Warnings – Nursing Mothers
“Results from a multiple dose study conducted in mothers soon after delivery indicates that flecainide is excreted in human breast milk in concentrations as high as 4 times (with average levels about 2.5 times) corresponding plasma levels; assuming a maternal plasma level at the top of the therapeutic range (1 mcg/mL), …”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Flecainide · Precautions/Warnings – Pediatric Use
“The safety and efficacy of flecainide in the fetus, infant, or child have not been established in double-blind, randomized, placebo-controlled trials.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA075442
- DailyMed (FDA label)FDA Flecainide
- MedlinePlus (NIH)Flecainide
- WHO ATC/DDDC01BC04
- Darooyab (Iran)Flecainide
🇮🇷 Registered in Iran Darooyab · G-1684/Flecainide
Dosage forms with Iranian generic codes, per Darooyab.
- 00536 · FLECAINIDE 100MG TAB · قرص فلکائینید ۱۰۰ میلیگرم
- 07909 · FLECAINIDE ACETATE 10MG/ML AMP · آمپول فلکائینید استات ۱۰ میلیگرم / میلیلیتر
- 11913 · FLECAINIDE ACETATE 50MG TAB · قرص فلکائینید استات ۵۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Flecainide · How SuppliedFDA Flecainide · Dosage and AdministrationFDA Flecainide · ContraindicationsFDA Flecainide · WarningsFDA Flecainide · Precautions/Warnings – PregnancyFDA Flecainide · Precautions/Warnings – Nursing MothersFDA Flecainide · Precautions/Warnings – Pediatric UseFDA Flecainide · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1684/Flecainide
- Clinical review⚠ Unverified